Schlagwort: Impact Life Sciences
‘Germany plays a leading role in radiopharmaceutical therapy’
As the global demand for targeted cancer therapies increases, Germany is emerging as a powerhouse of radiopharmaceutical research and innovation. Playing a leading role...
Now online: Second issue of „Impact Life Sciences“
In this issue's cover interview, Dr Andrew Cavey, CEO of ITM Isotope Technologies Munich SE, shares his views on Germany’s position as a biotech...
Nuclear medicine on the rise
Nuclear medicine is currently experiencing a dynamic resurgence, fuelled by groundbreaking innovations in theranostics, the rapid development of novel radiotracers, and the emergence of...
The use of AI in clinical trials
When using AI in clinical trials, stakeholders point to the challenges associated with the use of AI in clinical trials, amongst others the need...
‘Germany has enormous potential in terms of basic research’
Life sciences expert Dr Achim Plum has been on the management team of High-Tech Gründerfonds (HTGF) since January 2025, strengthening the life sciences sector...
First „Impact Life Sciences“ now online!
In the first issue of Impact Life Sciences, we conducted an in-depth interview with Dr Achim Plum – the new Managing Director with a...